Asset classes
Compare UTI Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.25 | 1.93 |
NAV | ₹289.36 | ₹39.25 |
Fund Started | 01 Aug 2005 | 25 Jun 2018 |
Fund Size | ₹1167.75 Cr | ₹4807.86 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.25
1.93
NAV
₹289.36
₹39.25
Fund Started
01 Aug 2005
25 Jun 2018
Fund Size
₹1167.75 Cr
₹4807.86 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 56.86% | 62.06% |
3 Year | 19.27% | 22.18% |
5 Year | 29.22% | 32.19% |
1 Year
56.86%
62.06%
3 Year
19.27%
22.18%
5 Year
29.22%
32.19%
Holding Analysis
Equity | 97.48% | 95.64% |
Cash | 2.41% | 4.36% |
Equity
97.48%
95.64%
Cash
2.41%
4.36%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.47% |
Cipla Ltd. | 6.65% |
Ajanta Pharma Ltd. | 5.56% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Apollo Hospitals Enterprise Ltd. | 3.84% |
Glenmark Pharmaceuticals Ltd. | 3.71% |
Eris Lifesciences Ltd. | 3.54% |
Aurobindo Pharma Ltd. | 3.36% |
Procter & Gamble Health Ltd. | 3.31% |
Fortis Healthcare Ltd. | 3.00% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 15.16% |
Cipla Ltd. | 6.77% |
Dr. Reddy's Laboratories Ltd. | 6.65% |
Lupin Ltd. | 4.92% |
Gland Pharma Ltd. | 4.91% |
Aurobindo Pharma Ltd. | 4.75% |
Apollo Hospitals Enterprise Ltd. | 4.42% |
Mankind Pharma Ltd. | 3.75% |
Divi's Laboratories Ltd. | 2.78% |
Healthcare Global Enterprises Ltd. | 2.44% |
Fund Manager
Name | Kamal Gada | Dharmesh Kakkad |
Start Date | 02 May 2022 | 23 Feb 2021 |
Name
Kamal Gada
Dharmesh Kakkad
Start Date
02 May 2022
23 Feb 2021
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 01 Aug 2005 | 25 Jun 2018 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
01 Aug 2005
25 Jun 2018
